Bridges Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,976
| Closed | -$216K | – | 411 |
|
|
2025
Q1 | $216K | Sell |
2,976
-10,384
| -78% | -$753K | ﹤0.01% | 381 |
|
|
2024
Q4 | $989K | Sell |
13,360
-3,268
| -20% | -$242K | 0.01% | 208 |
|
|
2024
Q3 | $1.1M | Sell |
16,628
-58,619
| -78% | -$3.87M | 0.02% | 194 |
|
|
2024
Q2 | $6.95M | Sell |
75,247
-86,165
| -53% | -$7.96M | 0.11% | 95 |
|
|
2024
Q1 | $15.4M | Sell |
161,412
-9,726
| -6% | -$929K | 0.48% | 49 |
|
|
2023
Q4 | $13M | Sell |
171,138
-42,775
| -20% | -$3.26M | 0.43% | 51 |
|
|
2023
Q3 | $14.8M | Sell |
213,913
-8,729
| -4% | -$605K | 0.53% | 47 |
|
|
2023
Q2 | $21M | Sell |
222,642
-3,583
| -2% | -$338K | 0.7% | 38 |
|
|
2023
Q1 | $18.7M | Buy |
226,225
+10,049
| +5% | +$831K | 0.66% | 41 |
|
|
2022
Q4 | $16.1M | Buy |
216,176
+46,634
| +28% | +$3.48M | 0.59% | 46 |
|
|
2022
Q3 | $14M | Buy |
169,542
+298
| +0.2% | +$24.6K | 0.54% | 47 |
|
|
2022
Q2 | $16.1M | Buy |
169,244
+1,851
| +1% | +$176K | 0.59% | 45 |
|
|
2022
Q1 | $19.7M | Buy |
167,393
+3,152
| +2% | +$371K | 0.61% | 43 |
|
|
2021
Q4 | $21.3M | Buy |
164,241
+2,128
| +1% | +$276K | 0.62% | 43 |
|
|
2021
Q3 | $18.4M | Buy |
162,113
+163
| +0.1% | +$18.5K | 0.58% | 46 |
|
|
2021
Q2 | $16.8M | Buy |
161,950
+2,791
| +2% | +$289K | 0.5% | 51 |
|
|
2021
Q1 | $13.3M | Buy |
159,159
+20,241
| +15% | +$1.69M | 0.39% | 58 |
|
|
2020
Q4 | $12.7M | Buy |
138,918
+26,436
| +24% | +$2.41M | 0.39% | 56 |
|
|
2020
Q3 | $8.98M | Buy |
112,482
+13,484
| +14% | +$1.08M | 0.3% | 64 |
|
|
2020
Q2 | $6.84M | Buy |
98,998
+30,745
| +45% | +$2.12M | 0.25% | 70 |
|
|
2020
Q1 | $4.29M | Buy |
+68,253
| New | +$4.29M | 0.19% | 82 |
|
|
2019
Q3 | – | Sell |
-10,533
| Closed | -$649K | – | 422 |
|
|
2019
Q2 | $649K | Buy |
+10,533
| New | +$649K | 0.02% | 256 |
|